内部人交易记录
首席执行官基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the detailed record of transactions filed by Cohen Yuval, 首席执行官. Insider active across 1 company, notably Corbus Pharmaceuticals Holdings, Inc.. Aggregated, 12 disclosures have been published. Breakdown: 3 buys · 3 sells. Total volume traded: €306k. Activity tracked since 9 March 2022. The latest transaction was disclosed on 7 August 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Cohen Yuval
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
17,000 股@ US$10.08210.0079% mcap23.7% 占其流量Common Stock, par value $0.0001 per shareSEC:0001193125-26-342485:0
13,871 股@ US$7.782619.0% 占其流量Common Stock, par value $0.0001 per shareSEC:0001193125-26-057159:0
50,000 股0Common Stock, par value $0.0001 per shareSEC:0001193125-26-015426:0
18,660 股@ US$4.2617.6% 占其流量Common Stock, par value $0.0001 per shareSEC:0001193125-25-251639:0
7,134 股@ US$8.755918.7% 占其流量Common Stock, par value $0.0001 per shareSEC:0000950170-25-022512:0
68,100 股0Common Stock, par value $0.0001 per shareSEC:0000950170-25-013697:0
16,830 股@ US$14.1069.1% 占其流量Common Stock, par value $0.0001 per shareSEC:0000950170-24-075071:0
73,947 股0Common Stock, par value $0.0001 per shareSEC:0001209191-24-003336:0
7,179 股@ US$4.9710.3% 占其流量Common StockSEC:0001209191-24-002419:0
3,800 股@ US$0.2640.3% 占其流量Common StockSEC:0001209191-22-045358:0
10,500 股@ US$0.250.4% 占其流量Common StockSEC:0001209191-22-029030:0
8,600 股@ US$0.370.6% 占其流量Common StockSEC:0001209191-22-017449:0
About Cohen Yuval
Cohen Yuval is Directeur Général and Chief Executive Officer at Corbus Pharmaceuticals Holdings, Inc. His 11 reported filings, all included in the available sample, cover the period from 2022-03-09 to 2026-02-18. In these recent filings, the total buy amount is EUR 6408 and the total sell amount is EUR 150666, and the most frequent transaction nature is Attribution.